C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2006
11/30/2006	US20060272054 Altering cellulose synthase levels in plants; transgenic plants; for modulating, in a transgenic plant, expression of the nucleic acids
11/30/2006	US20060272050 Polypeptides having antimicrobial activity and polynucleotides encoding same
11/30/2006	US20060272049 Insect resistance using inhibition of gene expression
11/30/2006	US20060272045 Brittle-2 regulatory elements for use in plants
11/30/2006	US20060272040 Method for producing a mammal provided with resistance to an alpha-herpes virus mediated infection and mamal obtained by implementing said method and said mamal's progeny
11/30/2006	US20060272037 Millisecond activation switch for seven-transmembrane proteins
11/30/2006	US20060272036 Ruminant mhc class-i-like fc receptors
11/30/2006	US20060270841 Assays to monitor amyloid precursor protein processing
11/30/2006	US20060270839 Crystallization of IGF-1
11/30/2006	US20060270838 covalent heterodimer of two different neurotrophins; which have multiple neurotrophic specificities; use in treatment of nervous system disorders
11/30/2006	US20060270836 EERgamma peptide fragment complexes and uses thereof in drug discovery
11/30/2006	US20060270835 Diagnosis and treatment of Alzheimer disease
11/30/2006	US20060270834 Fusion protein of a von Hippel-Lindau (VHL) peptide and a TAT peptide or an ANT peptide; used for inducing differentiation of neural stem cells into neurons without accompanying a risk such as cytotoxicity and infection; also claimed are the produced neurons
11/30/2006	US20060270833 Peptide complex
11/30/2006	US20060270831 Novel peptide dimers as agonists of the erythropoietin (EPO) receptor, and associated methods of synthesis and use
11/30/2006	US20060270829 G-csf conjugates
11/30/2006	US20060270710 Methods for inhibition of angiogenesis
11/30/2006	US20060270703 G-csf conjugates
11/30/2006	US20060270699 Stabilization of hypoxia inducible factor (HIF) alpha
11/30/2006	US20060270624 Gapped 2' modified oligonucleotides
11/30/2006	US20060270621 Inhibition of hair growth with RNAi targeting desmoglein 4 and nude mRNAs
11/30/2006	US20060270619 Polynucleotide used in diagnosis of cell proliferative disease, and as target molecules for developing drugs
11/30/2006	US20060270605 Compositions and methods for inhibiting cell growth and modulating gene expression
11/30/2006	US20060270604 Pharmaceutical preparations of Fn3 polypeptides for human treatments
11/30/2006	US20060270603 Amidated parathyroid hormone fragments and uses thereof
11/30/2006	US20060270602 Mutants of bone morphogenetic proteins
11/30/2006	US20060270601 ARTS C-terminus fragments and mimetics thereof
11/30/2006	US20060270600 Anti-cancer agents
11/30/2006	US20060270599 Inhibiting angiogenesis using molecules that enhance plasmin formation or prolong plasmin activity
11/30/2006	US20060270597 Compositions of THAP-family chemokine binding domains
11/30/2006	US20060270596 Compositions of THAP-family chemokine binding domains
11/30/2006	US20060270595 Nucleic acids encoding compositions of THAP-family chemokine binding domains
11/30/2006	US20060270593 Novel molecules of the PYRIN/NBS/LRR protein family and uses thereof
11/30/2006	US20060270591 Androgen receptor coregulators
11/30/2006	US20060270035 Inhibition of stem cell differentiation, enhancement of proliferation and selective induction of apoptosis by WNT factors
11/30/2006	US20060270019 Method for producing lactic acid bacterium culture containing bacteriocin and a method for preserving food products for by using it
11/30/2006	US20060270005 Genomic library of cyanophage s-2l and functional analysis
11/30/2006	US20060270003 Nucleotide sequences coding imterleukin-17 polypeptide for use in diagnosis, prevention and treatment of bone, autoimmune, skin and inflammatory disorders
11/30/2006	US20060270002 Factor VII or VIIa Polypeptide Variants
11/30/2006	US20060270001 Factor VII or VIIa Polypeptide Variants
11/30/2006	US20060270000 Factor VII or VIIa Polypeptide Variants
11/30/2006	US20060269999 Promoters
11/30/2006	US20060269998 Methods and compositions to modulate adhesion and stress tolerance in bacteria
11/30/2006	US20060269997 Vascular endothelial cell growth factor variants and uses thereof
11/30/2006	US20060269996 Human voltage gated sodium channel beta1A subunit and methods of use
11/30/2006	US20060269995 Novel assays utilizing nicotinic acetylcholine receptor subunits
11/30/2006	US20060269993 Mamalian chemokines and 7 transmembrane receptors; bound to MIP-3 alpha; labeled; fused to luciferase, bacterial beta -galactosidase, trpE, Protein A, beta -lactamase, alpha amylase, alcohol dehydrogenase, a FLAG tag, or yeast alpha mating factor; complexed with an antibody
11/30/2006	US20060269992 Producing a first thioredoxin polypeptide comprising thioredoxin, a modified thioredoxin, or a truncated thioredoxin; andincubating the first thioredoxin polypeptide with a protein-binding dye to form a first stained molecular weight marker
11/30/2006	US20060269991 T cell protein and nucleotides encoding the same
11/30/2006	US20060269990 Process for the preparation of recombinant polypeptides
11/30/2006	US20060269976 Method for reducing lysozyme enzymatic activity
11/30/2006	US20060269967 Novel diagnosis & treatment tools for cancer using the NRIP antibody and RNA interference
11/30/2006	US20060269960 Isolated peptides corresponding to amino acid requirements of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof
11/30/2006	US20060269959 Sequences of an Ih ion channel and use thereof
11/30/2006	US20060269957 Nucleotide sequences coding protein factors for use in identifying modulators for diagnosis, treatment and prevention of cell proliferative, metabolic, inflammatory, nervous system and immune disorders
11/30/2006	US20060269956 Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571
11/30/2006	US20060269954 Self-assembling recombinant papillomavirus capsid proteins
11/30/2006	US20060269953 Novel hepatitis B virus
11/30/2006	US20060269951 Inhibitors of autoinducer transporters
11/30/2006	US20060269936 Drug screening for agonists and antagonists to toll-like receptors using mutant TLR proteins containing deletions in extracellular leucine rich regions (LRRs); viricides, anticarcinogenic agents, antiallergens, antihistamines, bronchodilator agents; chronic obstructive pulmonary disease, asthma
11/30/2006	US20060269926 Novel dyes for the detection or quantification of desirable target molecules
11/30/2006	US20060269918 Compositions, splice variants and methods relating to colon specific genes and proteins
11/30/2006	US20060269917 Compositions, splice variants and methods relating to colon specific gene and proteins
11/30/2006	US20060269912 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
11/30/2006	US20060269572 Accelerated vaccination
11/30/2006	US20060269570 Recombinant double-stranded RNA phage, and use of the same
11/30/2006	US20060269566 Polypeptide comprising extracellular domain which induces T-cell proliferation response; gene therapy; vaccines; antiproliferative/antitumor agents; cytotoxic T-lymphocyte (CTLA)
11/30/2006	US20060269565 Administering a polypeptide fused to an Fc, has T-cell proliferation inhibiting activity to treat autoimmune encephalomyelitis
11/30/2006	US20060269564 Yersinia spp. polypeptides and methods of use
11/30/2006	US20060269563 NMB1343 from Neisseria meningitidis; provides a mutant toxin having a substitution at one or more of amino Glu-109, Glu-111 or Glu-120; has reduced or eliminated ADP-ribosyltransferase and/or NAD-glycohydrolase activity
11/30/2006	US20060269562 Polypeptides f' of the hepatitis c virus, t epitopeo, and the diagnostic and therapeutic applications thereof
11/30/2006	US20060269561 Compositions and methods for treatment of non-hodgkins lymphoma
11/30/2006	US20060269559 Novel human histone deacetylases
11/30/2006	US20060269557 Humanized anti-prostate stem cell antigen monoclonal antibody
11/30/2006	US20060269556 Mast cell activation using siglec 6 antibodies
11/30/2006	US20060269551 Reducing interleukin (IL-20) induced inflammation by administering antibody, fragment or single chain antibody; adult respiratory disease, psoriasis, eczema, dermatitis, septic shock, multiple organ failure, pneumonia, inflammatory bowel disease, arthritis, asthma, ulcerative colitis, Crohn*s disease
11/30/2006	US20060269546 Androgen-regulated PMEPA1 gene and polypeptides
11/30/2006	US20060269545 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
11/30/2006	US20060269541 S.agalactiae antigens I + II
11/30/2006	US20060269536 Inhibitor proteins of a protease and use thereof
11/30/2006	US20060269532 Compositions and methods for the therapy and diagnosis of prostate cancer
11/30/2006	US20060269529 Modified t lymphocytes and uses therefor
11/30/2006	US20060269523 Produced by a lactic acid producing bacterial strain having the identifying characteristics of a strain selected from NRRL B-30514, NRRL B-30510, NRRL B-30511, and NRRL B-30645; used for reducing levels of colonization by a target bacteria in animals, especially poultry
11/30/2006	US20060269516 Interferon-IgG fusion
11/30/2006	US20060269515 Interleukin-2 muteins
11/30/2006	US20060269478 Use of protein occlusion for the selective delivery of small molecules to targets
11/30/2006	US20060269477 ST receptor binding compounds and methods of using the same
11/30/2006	DE69735603T2 PTHrP Analogen PTHrP analogs
11/30/2006	DE102005022047A1 Bindungspartner des Plazentalen Wachstumsfaktors insbesondere gegen den Plazentalen Wachstumsfaktor gerichtete Antikörper, ihre Herstellung und Verwendung Binding partner of the placental growth factor, in particular against the placental growth factor antibodies directed, their preparation and use
11/30/2006	CA2631556A1 Functional epitopes of streptococcus pneumoniae psaa antigen and uses thereof
11/30/2006	CA2615415A1 Method for producing virus-type particles containing an active substance
11/30/2006	CA2609811A1 Angiotensin i - converting enzyme (ace) inhibitors
11/30/2006	CA2609613A1 Interferon-igg fusion
11/30/2006	CA2609473A1 A recombinant method for production of an erythropoiesis stimulating protein
11/30/2006	CA2609447A1 Polypeptides
11/30/2006	CA2609271A1 Novel substrate for rpn 11 enzymatic activity
11/30/2006	CA2609188A1 Apo-2 ligand/trail formulations
11/30/2006	CA2609164A1 Gene of transporter selective to mugineic acid-iron complex
11/30/2006	CA2608852A1 Chimeric proteins for measuring atp concentrations in pericellular space and related screening method
11/30/2006	CA2608398A1 Compositions and methods for treating hiv infection with cupredoxin and cytochrome c

1 ... 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 ... 2916